Terms: = Leukemia AND ETV5, P41161, 2119, ENSG00000244405, ERM AND Treatment
14 results:
1. Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India.
Chauhan P; Gupta A; Gopinathan M; Sanjeev ; Garg A; Khanna S; Gupta R; Rahman K; Chandra D; Singh MK; Nityanand S
Ann Hematol; 2022 Jun; 101(6):1261-1273. PubMed ID: 35325304
[TBL] [Abstract] [Full Text] [Related]
2. Mechanical stiffness softening and cell adhesion are coordinately regulated by erm dephosphorylation in KG-1 cells.
Kihara T; Matsumoto T; Nakahashi Y; Tachibana K
Hum Cell; 2021 Nov; 34(6):1709-1716. PubMed ID: 34312810
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India.
Phukan A; Mandal PK; Dolai TK
Ann Hematol; 2021 Jan; 100(1):85-96. PubMed ID: 33025163
[TBL] [Abstract] [Full Text] [Related]
4. Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling.
Yeoh AE; Li Z; Dong D; Lu Y; Jiang N; Trka J; Tan AM; Lin HP; Quah TC; Ariffin H; Wong L
Br J Haematol; 2018 Jun; 181(5):653-663. PubMed ID: 29808917
[TBL] [Abstract] [Full Text] [Related]
5. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract] [Full Text] [Related]
6. Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients.
Arvidsson G; Henriksson J; Sander B; Wright AP
Haematologica; 2018 Apr; 103(4):666-678. PubMed ID: 29449436
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms.
Molenaar RJ; Thota S; Nagata Y; Patel B; Clemente M; Przychodzen B; Hirsh C; Viny AD; Hosano N; Bleeker FE; Meggendorfer M; Alpermann T; Shiraishi Y; Chiba K; Tanaka H; van Noorden CJ; Radivoyevitch T; Carraway HE; Makishima H; Miyano S; Sekeres MA; Ogawa S; Haferlach T; Maciejewski JP
Leukemia; 2015 Nov; 29(11):2134-42. PubMed ID: 25836588
[TBL] [Abstract] [Full Text] [Related]
8. Activated erm protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25.
Zhang L; Xiao R; Xiong J; Leng J; Ehtisham A; Hu Y; Ding Q; Xu H; Liu S; Wang J; Tang DG; Zhang Q
PLoS One; 2013; 8(1):e52384. PubMed ID: 23326330
[TBL] [Abstract] [Full Text] [Related]
9. Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9.
Zhou B; Leng J; Hu M; Zhang L; Wang Z; Liu D; Tong X; Yu B; Hu Y; Deng C; Liu Y; Zhang Q
Leuk Res; 2010 Jun; 34(6):769-76. PubMed ID: 20036004
[TBL] [Abstract] [Full Text] [Related]
10. Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways.
Pignochino Y; Grignani G; Cavalloni G; Motta M; Tapparo M; Bruno S; Bottos A; Gammaitoni L; Migliardi G; Camussi G; Alberghini M; Torchio B; Ferrari S; Bussolino F; Fagioli F; Picci P; Aglietta M
Mol Cancer; 2009 Dec; 8():118. PubMed ID: 20003259
[TBL] [Abstract] [Full Text] [Related]
11. Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.
Specchia G; Pastore D; Carluccio P; Spinosa G; Giannoccaro M; Rizzi R; Mestice A; Liso V
Ann Hematol; 2007 Jun; 86(6):425-8. PubMed ID: 17364181
[TBL] [Abstract] [Full Text] [Related]
12. Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia.
Weihrauch MR; Staib P; Seiberlich B; Hoffmann M; Diehl V; Tesch H
Leuk Lymphoma; 2004 Apr; 45(4):699-704. PubMed ID: 15160942
[TBL] [Abstract] [Full Text] [Related]
13. P-glycoprotein-actin association through erm family proteins: a role in P-glycoprotein function in human cells of lymphoid origin.
Luciani F; Molinari A; Lozupone F; Calcabrini A; Lugini L; Stringaro A; Puddu P; Arancia G; Cianfriglia M; Fais S
Blood; 2002 Jan; 99(2):641-8. PubMed ID: 11781249
[TBL] [Abstract] [Full Text] [Related]
14. Methylation profiling in acute myeloid leukemia.
Toyota M; Kopecky KJ; Toyota MO; Jair KW; Willman CL; Issa JP
Blood; 2001 May; 97(9):2823-9. PubMed ID: 11313277
[TBL] [Abstract] [Full Text] [Related]
